GAT Therapeutics

Baldiri I Reixac, 4

08028 Barcelona

ES

GAT Therapeutics

Foundation date

03/06/2019

Sector

#Biotechnology - Therapeutics

Subsector

Therapeutic areas

GAT Therapeutics is an early stage biopharma targeting fibrosis and age-related diseases.

Upcoming events

Latest news

  • SeptiCyte® RAPID receives 510(k) clearance by US FDA

    Wednesday December 1st 2021

  • QbD and Inovigate launch Health to Market, a contract commercialization organization in life sciences

    Wednesday December 1st 2021

  • Dimitrios Mantzilas joins Precirix as Chief Technology Officer

    Wednesday December 1st 2021